RPbio Inc. Logo

RPbio Inc.

A global CDMO specializing in soft capsules, pharmaceuticals, and health functional foods.

314140 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
서울특별시 강남구 삼성로 634, 강남구
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

RPbio Inc. is a bio-health company specializing in the contract development and manufacturing (CDMO) of soft capsules, pharmaceuticals, and health functional foods. Established in 1983 as a joint venture between Daewoong Pharmaceutical and R.P. Scherer Corporation, the company leverages extensive expertise in advanced softgel technologies. RPbio provides comprehensive OEM/ODM services to domestic and international clients in the pharmaceutical and health supplement industries, positioning itself as a leading global producer of soft capsules.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 703.4 KB
2025-07-22 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.7 KB
2025-06-30 00:00
Board/Management Information
대표이사변경
Korean 9.2 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 623.2 KB
2025-03-31 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 21.7 KB
2025-03-21 00:00
Annual Report
사업보고서 (2024.12)
Korean 977.6 KB
2025-03-20 00:00
Audit Report / Information
감사보고서제출
Korean 18.3 KB
2025-03-14 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 11.2 KB
2025-03-14 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 69.6 KB
2025-02-14 00:00
Earnings Release
매출액또는손익구조30%(대규모법인은15%)이상변동
Korean 10.7 KB

Automate Your Workflow. Get a real-time feed of all RPbio Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for RPbio Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden 2CUREX
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden ABERA
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
Abliva Logo
Develops clinical-stage medicines for rare primary mitochondrial diseases to restore cell function.
Sweden ABLI
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
Access Bio, Inc. Logo
Develops and manufactures rapid diagnostic tests for infectious diseases for global health.
United States of America 950130
Active Biotech Logo
Develops immunology-based drugs for cancer and inflammatory diseases with high unmet medical need.
Sweden ACTI

Talk to a Data Expert

Have a question? We'll get back to you promptly.